Amantadine: An antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme

Brain Research

Volumn 749, Issue 2, 1997, Pages 290-294

  Kakkar, Rakesh ^a   Raju, Rajala V S ^a   Rajput, Ali H ^b   Sharma, Rajendra K ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

amantadine; calmodulin; inhibition; Parkinson's disease; phosphodiesterase

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CALMODULIN; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CATTLE; CONTROLLED STUDY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

AMANTADINE; ANIMALS; ANTIPARKINSON AGENTS; BRAIN; CALMODULIN; CATTLE; ISOENZYMES; KINETICS; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES;

EID: 0031055678     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01318-2     Document Type: Article

References (40)

1. Aoki, F.F. and Sitar, D.S., Clinical pharmacokinetics of amantadine hydrochloride, Clin. Pharmacokinet., 14 (1988) 35-51.
2. +-currents in the insulin secreting beta-cell line, Br. J. Pharmacol., 104 (1991) 579-584.
3. Beavo, J.A., Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms, Physiol. Rev., 75 (1995) 725-743.
4. Brenneman, D.E., Fitzgerald, S. and Litzinger, M.J., Neuronal survival during electrical blockade is increased by 8-bromocyclic adenosine 3',5'-monophosphate, J. Pharmacol. Exp. Ther., 233 (1985) 402-408.
5. Clapham, D.E., Calcium signalling, Cell, 80 (1995) 259-268.
6. Dansyz, W., Gossel, M., Zajaczkowski, W., Dill, D. and Quack, G., Are NMDA antagonists properties relevant for antiparkinsonian like activity in rats? Case of amantadine and memantine, J. Neural Transm. (PD Sect.), 7 (1994) 155-166.
7. De la Monte, S.M., Wells, S.E., Hedley-Whyte, E.T. and Growdon, J.H., Neuropathological distinction between Parkinson's dementia and Parkinson's disease, Ann. Neural., 26 (1989) 309-320.
8. Florio, V.A., Sonnenburg, W.K., Johnson, R., Kwak, K.S., Jensen, G.S., Walsh, K.A. and Beavo J.A., Phosphorylation of the 61-kDa calmodulin-stimulated cyclic nucleotide phosphodiesterase at serine 120 reduces its affinity for calmodulin, Biochemistry, 33 (1994) 8948-8954.
9. Hansen, R.S. and Beavo, J.A., Differential recognition of calmodulin-enzyme complexes by a conformation-specific anticalmodulin monoclonal antibody, J Biol. Chem., 261 (1986) 14636-14645.
10. +-induced degeneration, J. Neurosci. Res., 32 (1992) 190-201.
11. 2+ /calmodulin-dependent protein kinase II. J. Biol. Chem., 264 (1989) 10884-10887.
12. Klee, C.B., Concerted regulation of protein phosphorylation and dephosphorylation by calmodulin, Neurochem. Res., 16 (1991) 1059-1065.
13. 2+ and target proteins. In: P. Cohen and C.B. Klee (Eds.), Calmodulin. Molecular Aspects of Cell Regulation, Vol. 5, Elsevier, Amsterdam, 1988, pp. 35-56.
14. Kornhuber, J., Quack, G., Dansyz, W., Jellinger, K., Danielczyk, W., Gsell, W. and Riederer, P., Therapeutic brain concentration of the NMDA receptor antagonist amantadine, Neuropharmacology, 34 (1995) 713-721.
15. Kornhuber, J., Weller, M., Schoppmeyer, K. and Riederer, P., Amantadine and memantadine are NMDA receptor antagonists with neuroprotective properties. J. Neural Transm., 43 (1994) 91-104.
16. Manganiello, V.C., Murata, T., Taira, M., Belfrage, P. and Degerman, E., Diversity in cyclic nucleotide phosphodiesterase isoenzyme families, Arch. Biochem. Biophys., 322 (1995) 1-13.
17. Mcafee, D.A., Schorderet, M. and Greengard, P., Adenosine 3',5'-monophosphate in nervous tissue: increase associated with synaptic transmission, Science, 171 (1971) 1156-1158.
18. Mizoguchi, K., Yokoo, H., Yoshida, M., Tanaka, T. and Tanaka, M., Amantadine increases the extracellular dopamine levels in striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism, Brain Res., 662 (1994) 255-258.
19. Mutus, B., Karuppiah, N., Sharma, R.K. and MacManus, J.P., The differential stimulation of brain and heart cyclic-AMP phosphodiesterase by calmodulin, Biochem. Biophys. Res. Commun., 131 (1985) 500-506.
20. Nishino, N., Kitamura, N., Hashimoto, T. and Tanaka, C., Transmembrane signalling systems in the brain of patients with Parkinson's disease, Rev. Neurosci., 4 (1993) 213-222.
21. Parkes, J.D., Zilkha, K.J., Calver, D.M. and Knill Jones, R.P., Controlled trial of amantadine hydrochloride in Parkinson's disease, Lancet, 1 (1970) 259-262.
22. Rojas, P., Altagracia, M., Kravzov, J. and Rios, C., Amantadine increases striatal dopamine turnover in MPTP treated mice, Drug Dev. Res., 29 (1993) 222-226.
23. Rydel, R.E. and Greene. L.A., cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor, Proc. Natl. Acad. Sci. USA, 85 (1988) 1257-1261.
24. Sharma, R.K., Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase, Biochemistry, 30 (1991) 5963-5968.
25. Sharma, R.K., Adachi, A.M.. Adachi, K. and Wang, J.H., Demonstration of bovine brain CaM-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies, J. Biol. Chem., 259 (1984) 9248-9254.
26. 2+ /calmodulin dependent cyclic nucleotide phosphodiesterase. In: G. Dent, K. Rabe and C. Schudt (Eds.), The Handbook of Immunology and Pharmacology of Phosphodiesterase Inhibitors, Academic Press, New York, 1996, pp. 65-79.
27. Sharma, R.K. and Kalra, J., Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes, Biochem. J., 299 (1994) 97-100.
28. Sharma, R.K. and Kalra, J., Ginsenoides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes, Biochemistry, 32 (1994) 4975-4978.
29. Sharma, R.K. and Kalra, J., Molecular interaction between cAMP and calcium in calmodulin-dependent cyclic nucleotide phosphodiesterase system, Clin. Invest. Med., 17 (1994) 374-382.
30. Sharma, R.K. and Wang, J.H., Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase, Proc. Nail Acad. Sci. USA, 82 (1985) 2603-2607.
31. 2+ -dependent modulator protein, Adv. Cyclic Nucleotide Res., 10 (1979) 187-198.
32. Sharma, R.K. and Wang, J.H., Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase, an enzyme containing calmodulin as a subunit, J. Biol. Chem., 261 (1986) 14160-14166.
33. Sharma, R.K. and Wang, J.H., Regulation of 63 kDa subunit containing isozyme of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase by a calmodulin dependent protein kinase, J. Biol. Chem., 261 (1986) 1322-1328.
34. Stoof, J.C., Booij, J. and Drukarch, B., Amantadine as N-methyl-Daspartic acid receptor antagonist: new possibilities for therapeutic applications? Clin. Neural. Neurosurg., 94 (Suppl.) (1992) S4-S6.
35. 2 dopamine receptors in the efflux of cAMP from rat neostriatum, Nature, 294 (1981) 366-368.
36. Uitti, R.J., Rajput, A.H., Ahlskog, J.E., Offord, K.P., Schroeder, D.R., Ho, M.M., Prasad, M, Rajput, A. and Basran, P., Amantadine treatment is an independent predictor of improved survival in Parkinson's disease, Neurology, 46 (1996) 1551-1556.
37. Von Voigtlander, P.F. and Moore, K.E., Dopamine: release from the brain in vivo by amantadine, Science, 174 (1971) 408-410.
38. Wang, J.H., Sharma, R.K. and Mooibroek, M.J., Calmodulin-stimulated cyclic nucleotide phosphodiesterase, Mol. Pharmacol. Cell Regul., 2 (1990) 19-59.
39. Weller, M., Finiels-Marlier, F. and Paul, S.M., NMDA receptor mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantadine, Brain Res., 613 (1993) 143-148.
40. Zhang, G.Y., Wang, J.H. and Sharma, R.K., Purification and characterization of bovine brain calmodulin-dependent protein kinase. II. The significance of autophosphorylation in the regulation of 63 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme, Mol. Cell. Biochem., 122 (1993) 159-169.